By: The Sick Economist As another year comes to an end, and a new one approaches, we take...
Biotech Investing
Biotech Investing
Biotech investing means betting on scientific innovation. Let’s talk about how you can turn innovation into profit.
By Owen Marino, Biotech Analyst Mergers and acquisitions continue to be huge factors in the world of biotech. These...
By John Kehoe, Equity Analyst Gene editing technology is extremely popular right now within the biotech industry. The gene...
By John Kehoe, Equity Analyst Success within the biotech industry is extremely difficult. It is exceedingly rare for companies...
By Owen Marino, Technical Analyst While the recent groundbreaking news with pharma giant Biogen - the approval of its...
By Aidan Asbill, Biotech Analyst In 2018, Bluebird Bio’s ($BLUE) impressive cell-based therapies propelled the company to stock prices...
By John Kehoe, Equity Analyst In the biotech industry, companies that are successfully developing medicine rarely go bankrupt. These...
By John Kehoe, Biotech Analyst Some of the most exciting investing opportunities in the world of biotech exist within...
By Aidan Asbill, Biotech Analyst Intellia Therapeutics ($NTLA) shocked the gene-editing field with the announcement of data from the...
By Owen Marino, Biotech Analyst Arguably the hottest topic in biotech this past month has been the approval of...